Granada

• Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation
  2024-514991-41-01 4 Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised
  2024-512754-16-00 5 Prostate cancer
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient … Pending
  2024-517621-54-00 5 High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
• Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced br … Pending
  2024-518026-32-00 5 Invasive Breast Cancer
• A Study to Learn About the Study Medicine Called PF-07275315 in Adults with Moderate-To-Severe Long-Term Breathing Difficulty, Known by the … Pending
  2024-518587-12-00 4 MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
• REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending
  2024-519298-21-00 5 Cancer-Associated Thrombosis (CAT).
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tum … Pending
  2025-521209-42-00 6 advanced colorectal cancer with wild-type RAS and right primary tumour
• Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr … Pending
  2025-521301-40-00 6 Prevention of new morphometric vertebral fractures and/or worsening of
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Pending
  2025-521388-11-00 4 Staphylococcus aureus bacteraemia
• A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden … Pending
  2025-523259-72-00 5 Hidradenitis Suppurativa (HS)
• A Study to Learn about the Study Medicine called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers Pending
  2025-523526-40-00 9 Advanced Solid Tumors
• Clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis in recurrent urin … Pending
  2025-523922-42-00 6 recurrent urine infections
• A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder. Pending
  2025-524488-18-00 4 Muscle-invasive Bladder Cancer
• Optimizing Aspirin Use for Preeclampsia Prevention Pending
  2025-524646-94-00 11 Obstetrics – Preeclampsia
• Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES) Recruiting
  2025-521709-42-00 5 2026-06-23 Allergic rhinoconjunctivitis with or without asthma due to clinically
• Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Recruiting
  2025-524103-69-00 10 2026-06-10 Chronic Venous Insufficiency
• ​​AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors … Recruiting
  2025-524056-63-00 1 2026-06-05 microsatellite instability high/mismatch repair deficient (MSI-H/dMMR)
• Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m … Recruiting
  2025-524408-30-01 5 2026-06-05 Metastatic hormone-sensitive prostate cancer
• PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Recruiting
  2025-523425-17-00 4 2026-06-03 Proteinuric kidney diseases
• Study to Assess K1-70 in Participants with Active Thyroid Eye Disease Recruiting
  2024-519292-26-00 4 2026-05-28 Graves’ disease and active thyroid eye disease
• MAVRiC studies 2L treatment with AV in patients with CLL/SLL who have relapsed after a course of BTKi + BCL2i combination, with and without … Recruiting
  2024-518858-17-00 4 2026-05-22 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Showing 1–24 of 381 trials